Started minoxidil in February 2025, this is September 2024–>July 2025 Progress Pictures 7/25/2025
The user started oral minoxidil in February 2025 and noticed hair improvement, but paused due to pregnancy. They experienced minimal shedding and some facial hair growth as a side effect.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity I post relatively a lot here. I knew I could help more people like me. Because I learned a lot from here. I actually met good people here, from afar, who helped me grow my hair. As you can see, I was almost bald at age 34, and today I am 35.5 with very good hair. Oral Propecia, topical Minoxidil..
A user shared their successful hair regrowth journey using oral Propecia, topical Minoxidil, Ketozol shampoo, a derma roller, strength training, Omega 3, and Biotin. They experienced initial shedding but saw significant improvement in hair growth after 3-4 months.
community Finasterid+ oral Minoxidil 8 month progress
The user experienced significant hair shedding initially but saw progress after 8 months using 1.25 mg of oral finasteride and minoxidil. They noticed increased hair growth on their eyelashes, eyebrows, and body, and considered increasing the dosage but decided to maintain the current regimen.
community Started using topical minoxidil from kirkland (have been on oral Minoxidil 5mg daily for a year with no results) all of a sudden I start growing hair? What the F?
Topical minoxidil from Kirkland led to noticeable hair growth for the user, unlike oral minoxidil, which showed no results after a year. Other users shared similar experiences, suggesting topical minoxidil might be more effective than oral for some individuals.
community Oral Minoxidil worse hair after 1 year
The user switched from topical to oral Minoxidil and Finasteride but saw no improvement after a year, with hair appearing thinner. They recently switched to Dutasteride, hoping for better results.
community for anyone who is on the fence about oral minoxidil should read this NYT article it might help. it's an old one but people might need a refresher. https://www.nytimes.com/2022/08/18/health/minoxidil-hair-loss-pills.html
Oral minoxidil is more effective than topical for hair regrowth but may cause unwanted body hair growth and cardiovascular side effects. Some users experience positive results, while others discontinue use due to side effects like chest pain.
Related Research
6 / 6 resultsresearch Low-dose oral minoxidil in a case of short anagen syndrome
The study explores the potential effectiveness of low-dose oral minoxidil in treating short anagen hair syndrome, suggesting it may be a viable treatment option despite the condition often resolving spontaneously with puberty.
research SUMMARIES OF PAPERS
Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.
research Tissue Engineering and Regeneration of the Human Hair Follicle in Androgenetic Alopecia: Literature Review
This review examines current and potential tissue engineering strategies for hair follicle regeneration in androgenetic alopecia but does not provide new clinical results, highlighting the need for further research and development.
research Alopecia and Thyroid Disease
Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.
research Facial hair enhancement with minoxidil—an off-label use
This report describes the case of identical twin males, where one applied topical 5% minoxidil for over a year on the beard and mustache area and the other did not, highlighting the anecdotal use of minoxidil for facial hair enhancement.
research Cutaneous adverse effects of targeted therapies
This review discusses skin-related toxicities associated with targeted cancer therapies and emphasizes the need for dermatologists to understand and manage these adverse effects, but reports no new experimental results.